Evidence for an interaction between the Galactic Center clouds M0.10-0.08 and M0.11-0.11

We present high-resolution (~2-3"; ~0.1 pc) radio observations of the Galactic center cloud M0.10-0.08 using the Very Large Array at K and Ka band (~25 and 36 GHz). The M0.10-0.08 cloud is located in a complex environment near the Galactic center Radio Arc and the adjacent M0.11-0.11 molecular cloud. From our data, M0.10-0.08 appears to be a compact molecular cloud (~3 pc) that contains multiple compact molecular cores (5+; <0.4 pc). In this study we detect a total of 15 molecular transitions in M0.10-0.08 from the following molecules: NH3, HC3N, CH3OH, HC5N, CH3CN, and OCS. We have identified more than sixty 36 GHz CH3OH masers in M0.10-0.08 with brightness temperatures above 400 K and 31 maser candidates with temperatures between 100-400 K. We conduct a kinematic analysis of the gas using NH3 and detect multiple velocity components towards this region of the Galactic center. The bulk of the gas in this region has a velocity of 51.5 km/s (M0.10-0.08) with a lower velocity wing at 37.6 km/s. We also detect a relatively faint velocity component at 10.6 km/s that we attribute to being an extension of the M0.11-0.11 cloud. Analysis of the gas kinematics, combined with past X-ray fluorescence observations, suggests M0.10-0.08 and M0.11-0.11 are located in the same vicinity of the Galactic center and could be physically interacting.Comment: Accepted for publication in the Astrophysical Journa

The Optical Green Valley Versus Mid-infrared Canyon in Compact Groups

Compact groups of galaxies provide conditions similar to those experienced by galaxies in the earlier universe. Recent work on compact groups has led to the discovery of a dearth of mid-infrared transition galaxies (MIRTGs) in Infrared Array Camera (3.6-8.0 micrometers) color space as well as at intermediate specific star formation rates. However, we find that in compact groups these MIRTGs have already transitioned to the optical ([gr]) red sequence. We investigate the optical color-magnitude diagram (CMD) of 99 compact groups containing 348 galaxies and compare the optical CMD with mid-infrared (mid-IR) color space for compact group galaxies. Utilizing redshifts available from Sloan Digital Sky Survey, we identified new galaxy members for four groups. By combining optical and mid-IR data, we obtain information on both the dust and the stellar populations in compact group galaxies. We also compare with more isolated galaxies and galaxies in the Coma Cluster, which reveals that, similar to clusters, compact groups are dominated by optically red galaxies. While we find that compact group transition galaxies lie on the optical red sequence, LVL (Local Volume Legacy) + (plus) SINGS (Spitzer Infrared Nearby Galaxies Survey) mid-IR (infrared) transition galaxies span the range of optical colors. The dearth of mid-IR transition galaxies in compact groups may be due to a lack of moderately star-forming low mass galaxies; the relative lack of these galaxies could be due to their relatively small gravitational potential wells. This makes them more susceptible to this dynamic environment, thus causing them to more easily lose gas or be accreted by larger members

CMZoom IV. Incipient High-Mass Star Formation Throughout the Central Molecular Zone

In this work, we constrain the star-forming properties of all possible sites of incipient high-mass star formation in the Milky Way's Galactic Center. We identify dense structures using the CMZoom 1.3mm dust continuum catalog of objects with typical radii of $\sim$0.1pc, and measure their association with tracers of high-mass star formation. We incorporate compact emission at 8, 21, 24, 25, and 70um from MSX, Spitzer, Herschel, and SOFIA, catalogued young stellar objects, and water and methanol masers to characterize each source. We find an incipient star formation rate (SFR) for the CMZ of ~0.08 Msun yr^{-1} over the next few 10^5 yr. We calculate upper and lower limits on the CMZ's incipient SFR of ~0.45 Msun yr^{-1} and ~0.05 Msun yr^{-1} respectively, spanning between roughly equal to and several times greater than other estimates of CMZ's recent SFR. Despite substantial uncertainties, our results suggest the incipient SFR in the CMZ may be higher than previously estimated. We find that the prevalence of star formation tracers does not correlate with source volume density, but instead ~75% of high-mass star formation is found in regions above a column density ratio (N_{SMA}/N_{Herschel}) of ~1.5. Finally, we highlight the detection of ``atoll sources'', a reoccurring morphology of cold dust encircling evolved infrared sources, possibly representing HII regions in the process of destroying their envelopes.Comment: Accepted for publication in Ap

CMZoom: Survey Overview and First Data Release

We present an overview of the CMZoom survey and its first data release. CMZoom is the first blind, high-resolution survey of the Central Molecular Zone (CMZ; the inner 500 pc of the Milky Way) at wavelengths sensitive to the pre-cursors of high-mass stars. CMZoom is a 500-hour Large Program on the Submillimeter Array (SMA) that mapped at 1.3 mm all of the gas and dust in the CMZ above a molecular hydrogen column density of 10^23 cm^-2 at a resolution of ~3" (0.1 pc). In this paper, we focus on the 1.3 mm dust continuum and its data release, but also describe CMZoom spectral line data which will be released in a forthcoming publication. While CMZoom detected many regions with rich and complex substructure, its key result is an overall deficit in compact substructures on 0.1 - 2 pc scales (the compact dense gas fraction: CDGF). In comparison with clouds in the Galactic disk, the CDGF in the CMZ is substantially lower, despite having much higher average column densities. CMZ clouds with high CDGFs are well-known sites of active star formation. The inability of most gas in the CMZ to form compact substructures is likely responsible for the dearth of star formation in the CMZ, surprising considering its high density. The factors responsible for the low CDGF are not yet understood but are plausibly due to the extreme environment of the CMZ, having far-reaching ramifications for our understanding of the star formation process across the cosmos.Comment: Accepted for Publication in ApJ

CMZoom III: Spectral Line Data Release

We present an overview and data release of the spectral line component of the SMA Large Program, \textit{CMZoom}. \textit{CMZoom} observed $^{12}$CO(2-1), $^{13}$CO(2-1) and C$^{18}$O(2-1), three transitions of H$_{2}$CO, several transitions of CH$_{3}$OH, two transitions of OCS and single transitions of SiO and SO, within gas above a column density of N(H$_2$)$\ge 10^{23}$\,cm$^{-2}$ in the Central Molecular Zone (CMZ; inner few hundred pc of the Galaxy). We extract spectra from all compact 1.3\,mm \emph{CMZoom} continuum sources and fit line profiles to the spectra. We use the fit results from the H$_{2}$CO 3(0,3)-2(0,2) transition to determine the source kinematic properties. We find $\sim 90$\% of the total mass of \emph{CMZoom} sources have reliable kinematics. Only four compact continuum sources are formally self-gravitating. The remainder are consistent with being in hydrostatic equilibrium assuming that they are confined by the high external pressure in the CMZ. Based on the mass and density of virially bound sources, and assuming star formation occurs within one free-fall time with a star formation efficiency of $10\% - 75\%$, we place a lower limit on the future embedded star-formation rate of $0.008 - 0.06$\,M$_{\odot}$\,yr$^{-1}$. We find only two convincing proto-stellar outflows, ruling out a previously undetected population of very massive, actively accreting YSOs with strong outflows. Finally, despite having sufficient sensitivity and resolution to detect high-velocity compact clouds (HVCCs), which have been claimed as evidence for intermediate mass black holes interacting with molecular gas clouds, we find no such objects across the large survey area.Comment: 44 pages, 41 figure

A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development

BACKGROUND: Some years ago we established an N-ethyl-N-nitrosourea screen for modifiers of transgene variegation in the mouse and a preliminary description of the first six mutant lines, named MommeD1-D6, has been published. We have reported the underlying genes in three cases: MommeD1 is a mutation in SMC hinge domain containing 1 (Smchd1), a novel modifier of epigenetic gene silencing; MommeD2 is a mutation in DNA methyltransferase 1 (Dnmt1); and MommeD4 is a mutation in Smarca 5 (Snf2h), a known chromatin remodeler. The identification of Dnmt1 and Smarca5 attest to the effectiveness of the screen design. RESULTS: We have now extended the screen and have identified four new modifiers, MommeD7-D10. Here we show that all ten MommeDs link to unique sites in the genome, that homozygosity for the mutations is associated with severe developmental abnormalities and that heterozygosity results in phenotypic abnormalities and reduced reproductive fitness in some cases. In addition, we have now identified the underlying genes for MommeD5 and MommeD10. MommeD5 is a mutation in Hdac1, which encodes histone deacetylase 1, and MommeD10 is a mutation in Baz1b (also known as Williams syndrome transcription factor), which encodes a transcription factor containing a PHD-type zinc finger and a bromodomain. We show that reduction in the level of Baz1b in the mouse results in craniofacial features reminiscent of Williams syndrome. CONCLUSIONS: These results demonstrate the importance of dosage-dependent epigenetic reprogramming in the development of the embryo and the power of the screen to provide mouse models to study this process

Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength.

Osteoporosis is characterized by low bone mineral density (BMD) and fragility fracture and affects over 200 million people worldwide. Bone quality describes the material properties that contribute to strength independently of BMD, and its quantitative analysis is a major priority in osteoporosis research. Tissue mineralization is a fundamental process requiring calcium and phosphate transporters. Here we identify impaired bone quality and strength in Slc20a2-/- mice lacking the phosphate transporter SLC20A2. Juveniles had abnormal endochondral and intramembranous ossification, decreased mineral accrual, and short stature. Adults exhibited only small reductions in bone mass and mineralization but a profound impairment of bone strength. Bone quality was severely impaired in Slc20a2-/- mice: yield load (-2.3 SD), maximum load (-1.7 SD), and stiffness (-2.7 SD) were all below values predicted from their bone mineral content as determined in a cohort of 320 wild-type controls. These studies identify Slc20a2 as a physiological regulator of tissue mineralization and highlight its critical role in the determination of bone quality and strength. © 2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc

Accelerating functional gene discovery in osteoarthritis.

Osteoarthritis causes debilitating pain and disability, resulting in a considerable socioeconomic burden, yet no drugs are available that prevent disease onset or progression. Here, we develop, validate and use rapid-throughput imaging techniques to identify abnormal joint phenotypes in randomly selected mutant mice generated by the International Knockout Mouse Consortium. We identify 14 genes with functional involvement in osteoarthritis pathogenesis, including the homeobox gene Pitx1, and functionally characterize 6 candidate human osteoarthritis genes in mouse models. We demonstrate sensitivity of the methods by identifying age-related degenerative joint damage in wild-type mice. Finally, we phenotype previously generated mutant mice with an osteoarthritis-associated polymorphism in the Dio2 gene by CRISPR/Cas9 genome editing and demonstrate a protective role in disease onset with public health implications. We hope this expanding resource of mutant mice will accelerate functional gene discovery in osteoarthritis and offer drug discovery opportunities for this common, incapacitating chronic disease